Why Bay Area’s Intuitive Surgical Could be the Top Medtech Stock Right Now

Gemini Therapeutics Banks $42.5M to Bring Precisio

Gemini Therapeutics Banks $42.5M to Bring Precisio

Over the years, Intuitive Surgical has carved out a place for itself as one of the few providers of minimally-invasive, robotically-assisted surgical equipment.

Investors who want a lucrative investment but can’t sink their money into a $450 million Leonardo da Vinci painting should consider the stock of Intuitive Surgical, CNBC’s Jim Cramer said on Monday.

“I think it’s safe to say that this is the da Vinci of stocks, and not just because they stole the guy’s name,” the “Mad Money” host said, referring to the company’s robotic surgical system named da Vinci. “Just like the painting that sold last week, Intuitive Surgical’s share price keeps roaring higher, more than doubling over the past two years, up over 86 percent since the beginning of 2017.”

MORE ON THIS TOPIC